Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

BOZICEVIC, FIELD & FRANCIS LLP

EAST PALO ALTO, CA US

1. 20110046042 Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof 02-24-2011
2. 20110046038 Polypeptide-Polymer Conjugates and Methods of Use Thereof 02-24-2011
3. 20110044911 Use of Functionalized Magnetic Nanoparticles in Cancer Detection and Treatment 02-24-2011
4. 20110039100 Method for Making a 3D Nanostructure Having a Nanosubstructure, and an Insulating Pyramid Having a Metallic Tip, a Pyramid Having Nano-Apertures and Horizontal and/or Vertical Nanowires Obtainable by this Method 02-17-2011
5. 20110036661 Earpiece Member - ear tip or ear plug comprises a body portion having flexible peripheral rib elements projecting therefrom to provide a comfortable and 02-17-2011
6. 20110034541 Inhibitors of DNA Immunostimulatory Sequence Activity 02-10-2011
7. 20110032121 Method, System, And Optical Communication Assembly For Obtaining Traffic Information 02-10-2011
8. 20110030071 Transgenic Animal Model of Cancer and Methods of Use 02-03-2011
9. 20110029030 Methods and Compositions for Treating a Disease Condition in a Subject 02-03-2011
10. 20110027248 Sugar Chain-Related Gene and Use Thereof 02-03-2011
11. 20110025016 VEHICLE - , comprising a frame and a number of wheels 02-03-2011
12. 20110020934 Fusion Partner for Production of Monoclonal Rabbit Antibodies 01-27-2011
13. 20110020401 TISSUE TARGETED ANTIGENIC ACTIVATION OF THE IMMUNE RESPONSE TO TREAT CANCERS 01-27-2011
14. 20110020314 IDENTIFYING HAEMATOPOIETIC STEM CELLS BASED ON CELL SURFACE MARKERS 01-27-2011
15. 20110020281 Methods for Treating a Plant Exposed to a Phytotoxicant 01-27-2011
16. 20110015188 Treatment of Seasonal Conditions - Multi-dose active agent packages and methods for using the same for treating a subject for a condition are provided 01-20-2011
17. 20110015122 HEPATITIS B VIRUS-BINDING POLYPEPTIDES AND METHODS OF USE THEREOF 01-20-2011
18. 20110014696 METHOD FOR PRODUCING DENDRITIC CELLS - Disclosed are embryonic stem cell-derived dendritic cells genetically modified immature dendritic cells capable 01-20-2011
19. 20110014600 Microfluidic Magnetophoretic Device and Methods for Using the Same 01-20-2011
20. 20110013820 METHODS AND SYSTEMS FOR MEASURING A PROPERTY OF A MACROMOLECULE 01-20-2011
21. 20110009694 HAND-HELD MINIMALLY DIMENSIONED DIAGNOSTIC DEVICE HAVING INTEGRATED DISTAL END VISUALIZATION 01-13-2011
22. 20110008829 Use of Synthetic Scaffolds for the Production of Biosynthetic Pathway Products 01-13-2011
23. 20110008498 Methods and Compositions for Preparing Consumables with Optical Shifting Properties 01-13-2011
24. 20110008367 ANTI-VEGF ANTIBODY - antibody is provided 01-13-2011
25. 20110004219 Calcium Phosphate Cements Comprising Autologous Bone 01-06-2011
26. 20110003751 Novel Immunoregulatory Peptides, Compositions and Uses Thereof 01-06-2011
27. 20110003336 Methods for Increasing the Therapeutic Efficacy of Immunoglobulin G Class 3 (IgG3) Antibodies 01-06-2011
28. 20110002967 Methods of Transdermally Administering an Indole Serotonin Receptor Agonist and Transdermal Compositions for Use in the Same 01-06-2011
29. 20110000283 Method for Manufacturing and Testing Micro Fluidic Chips 01-06-2011
30. 20100331195 Sequencing Nucleic Acid Polymers with Electron Microscopy 12-30-2010
31. 20100330114 Use of SIRT1 Activators or Inhibitors to Modulate an Immune Response 12-30-2010
32. 20100330006 Antimicrobial lotion compositions - Methods of using absorption enhancer as a component of skin care compositions for moisturizing and protecting the 12-30-2010
33. 20100329993 METHOD OF FIXING AND EXPRESSING PHYSIOLOGICALLY ACTIVE SUBSTANCE 12-30-2010
34. 20100322874 ABSORBANT/COMPLIANT SOLUTION-FREE CLEANING AND MULTIACTIVE COMPOSITIONS 12-23-2010
35. 20100320092 Electrochemical Detection of a Metal - Labelled Analyte 12-23-2010
36. 20100318193 TOPOGRAPHICALLY ENGINEERED STRUCTURES AND METHODS FOR USING THE SAME IN REGENERATIVE MEDICINE APPLICATIONS 12-16-2010
37. 20100317721 Compositions and Methods for Treating Tumors, Fibrosis, and Pulmonary Alveolar Proteinosis 12-16-2010
38. 20100317539 Library of Engineered-Antibody Producing Cells 12-16-2010
39. 20100317104 CELL CULTURE MEDIA - serum-free media composition for maintenance or directed differentiation of human embryonic stem cells toward particular cell 12-16-2010
40. 20100317071 Method for the Enzymatic Production of Fatty Alcohol and/or Fatty Acid 12-16-2010
41. 20100316608 Method of Determining A Response To Treatment With Immunomodulatory Composition 12-16-2010
42. 20100310613 DRUG DELIVERY SYSTEM - for the controlled release of a pharmaceutically-active compound by oral route comprises an intercalate of a layered double 12-09-2010
43. 20100307946 MEMBRANE HOLDER - comprising a number of cartridges for holding elongate filter membranes 12-09-2010
44. 20100306700 Electronic Land and Sea Map System - electronic land or sea map system comprising: an electronic memory of at least two land or sea maps 12-02-2010
45. 20100304985 METHODS AND COMPOSITIONS FOR DETERMINING WHETHER A SUBJECT CARRIES A DISEASE ASSOCIATED GENE MUTATION COMMON IN JEWISH POPULATIONS 12-02-2010
46. 20100298393 Modulation of Growth Hormone, DHEA, and Cortisol with Positive Modulators of AMPA Type Glutamate Receptors 11-25-2010
47. 20100297176 Polyinosinic Acid - Polycytidylic Acid - Based Adjuvant 11-25-2010
48. 20100297163 RECOMBINANT MALARIA VACCINE - The present invention refers to a recombinant malaria vaccine and a method for its manufacture 11-25-2010
49. 20100297102 SEROTONIN 5-HT3A RECEPTORS IN TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS 11-25-2010
50. 20100292684 TISSUE MODIFICATION DEVICES AND METHODS OF THE SAME 11-18-2010
51. 20100291220 ANTIBIOTIC FORMULATION AND METHOD OF TREATMENT 11-18-2010
52. 20100287631 WNT PATHWAY MUTATIONS IN CANCER STEM CELLS 11-11-2010
53. 20100286734 Treatment of Conditions Through Modulation of the Autonomic Nervous System 11-11-2010
54. 20100286477 INTERNAL TISSUE VISUALIZATION SYSTEM COMPRISING A RF-SHIELDED VISUALIZATION SENSOR MODULE 11-11-2010
55. 20100286261 SUBSTITUTED N-ACYL HOMOSERINE LACTONES - The substituted N-acyl homoserine lactones have the formula wherein R is a saturated or unsaturated straight 11-11-2010
56. 20100285189 Filtering and/or Flocculating Aids for the Purification of Liquid Foods 11-11-2010
57. 20100285137 ANTIBIOTIC/BONE MORPHOGENIC PROTEIN FORMULATION AND METHOD OF TREATMENT 11-11-2010
58. 20100285067 INTERFERON-BETA PRODUCTION MODULATING LISTERIA STRAINS AND METHODS FOR USING SAME 11-11-2010
59. 20100284993 Enhancing the Efficacy of Anti-Infective Therapeutics 11-11-2010
60. 20100284580 TISSUE VISUALIZATION SYSTEMS AND METHODS FOR USING THE SAME 11-11-2010
61. 20100280116 LINOLEIC ACID ACTIVE AGENTS FOR ENHANCING PROBABILITY OF BECOMING PREGNANT 11-04-2010
62. 20100279380 Methods for Degrading Toxic Compounds - bacteria bacterial extracts supernatants obtained from the culturing of said bacteria 11-04-2010
63. 20100278936 COMPOSITION FOR TREATING SKIN LESIONS - composition for topical treatment of skin and mucosal membrane lesions comprising a synergistic combination of 11-04-2010
64. 20100276505 DRILLING IN STRETCHED SUBSTRATES - method and apparatus for drilling a plurality of holes in a stretched substrate in at least two directions not in the 11-04-2010
65. 20100275961 Tent with Locators for Poles - Tent structures include a plurality of upright poles 11-04-2010
66. 20100274183 DEVICE FOR READYING A NEEDLE FREE INJECTOR FOR DELIVERY 10-28-2010
67. 20100273839 Compounds Having Activity in Correcting Mutant-CFTR Processing and Uses Thereof 10-28-2010
68. 20100273161 DETECTION OF BACTERIA BELONGING TO THE GENUS CAMPYLOBACTER BY TARGETING CYTOLETHAL DISTENDING TOXIN 10-28-2010
69. 20100268478 Sequencing Nucleic Acid Polymers with Electron Microscopy 10-21-2010
70. 20100267996 Alcohol Dehydration - Catalyst compositions are disclosed exhibiting activity for dehydrating an alcohol the composition comprising a source of a Group 10-21-2010
71. 20100267157 Sequencing Nucleic Acid Polymers with Electron Microscopy 10-21-2010
72. 20100267156 Sequencing Nucleic Acid Polymers with Electron Microscopy 10-21-2010
73. 20100267155 Sequencing Nucleic Acid Polymers with Electron Microscopy 10-21-2010
74. 20100267154 Sequencing Nucleic Acid Polymers with Electron Microscopy 10-21-2010
75. 20100267153 Sequencing Nucleic Acid Polymers with Electron Microscopy 10-21-2010
76. 20100267152 Sequencing Nucleic Acid Polymers with Electron Microscopy 10-21-2010
77. 20100266492 COMPOUNDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOIETIES TO NERVE CELLS 10-21-2010
78. 20100262220 Expandable Vessel Harness for Treating Vessel Aneurysms 10-14-2010
79. 20100261176 Methods of Tissue-Based Diagnosis - The current invention provides methods as well as compositions useful in such methods involving application of 10-14-2010
80. 20100260762 De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy 10-14-2010
81. 20100260732 ROLE FOR SRY IN PARKINSON'S DISEASE - method for treating or preventing Parkinson's disease in a patient 10-14-2010
82. 20100260669 Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System 10-14-2010
83. 20100254903 Substituted Aryl-Fluoroborates as Imaging Agents 10-07-2010
84. 20100250201 Method and System for Improved Optical Modeling of Gemstones 09-30-2010
85. 20100248238 Detection Of Bacteria Belonging to the Genus Campylobacter By Targeting Cytolethal Distending Toxin 09-30-2010
86. 20100248206 Method of Isolating Stem and Progenitor Cells From Placenta 09-30-2010
87. 20100247693 COSMETIC FORMULATION TO TREAT ROSACEA TELANGIECTASIA 09-30-2010
88. 20100247223 STYLUS-SUBSTRATE SYSTEM FOR DIRECT IMAGING, DRAWING, AND RECORDING 09-30-2010
89. 20100242142 SCANNING PROBE MICROSCOPE - comprising: a specimen holder holding a specimen 09-23-2010
90. 20100240075 COMPLEMENT FACTOR H-BASED ASSAYS FOR SERUM BACTERICIDAL ACTIVITY AGAINST NEISSERIA MENINGITIDIS 09-23-2010
91. 20100235104 Methods for Classification of Toxic Agents and Counteragents 09-16-2010
92. 20100234828 Methods and Compositions for Facilitating Arterial Access 09-16-2010
93. 20100234581 THERMOSTABLE XYLOSE ISOMERASE ENZYMES - isolated polypeptide characterised in that it comprises an amino acid sequence having at least 80% identity to a 09-16-2010
94. 20100233020 METHOD AND DEVICE FOR DISINFECTING A SPACE 09-16-2010
95. 20100228225 METHOD AND SYSTEM FOR DELIVERY OF NEUROTOXINS 09-09-2010
96. 20100226970 Cationic liposome delivery of taxanes to angiogenic blood vessels 09-09-2010
97. 20100224853 SEMICONDUCTOR NANOCRYSTAL PROBES FOR BIOLOGICAL APPLICATIONS AND PROCESS FOR MAKING AND USING SUCH PROBES 09-09-2010
98. 20100221732 METHODS AND COMPOSITIONS FOR EVALUATING CHRONIC IMMUNE DISEASES 09-02-2010
99. 20100216842 Narcotic Emulsion Formulations for Treatment of Cancer Pain 08-26-2010
100. 20100216125 NUCLEIC ACID ANALYSIS USING SEQUENCE TOKENS 08-26-2010
101. 20100210707 Small Activating RNA Molecules and Methods of Use 08-19-2010
102. 20100210596 USE OF AMINOPYRIMIDINE COMPOUNDS IN THE TREATMENT OF IMMUNE DISORDERS 08-19-2010
103. 20100210543 Aldehyde-Tagged Protein-Based Drug Carriers and Methods of Use 08-19-2010
104. 20100209538 PH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY 08-19-2010
105. 20100209531 Oxides for Wound Healing and Body Repair 08-19-2010
106. 20100209415 CHEMOTHERAPEUTIC METHODS AND COMPOSITIONS 08-19-2010
107. 20100204059 CDR-Anchored Amplification Method - method of obtaining nucleic acid encoding a plurality of antibodies is provided 08-12-2010
108. 20100203107 Methods of Administering a Dermatological Agent to a Subject 08-12-2010
109. 20100199363 ENZYMES FOR DEGRADING HERBICIDES - new type of enzyme which is able to degrade amine-containing herbicides such as glyphosate and glufosinate 08-05-2010
110. 20100196939 Diagnosis of Conditions Associated with Decreased Arginine Bioavailability 08-05-2010
111. 20100196241 Methods and Systems for Reducing Particulate Matter in a Gaseous Stream 08-05-2010
112. 20100187228 Folding containers - collapsible air freight container also known as a unit load device comprises a standard base commonly used on unit load devices 07-29-2010
113. 20100185186 METHODS OF TREATING A CARDIAC ARRHYTHMIA BY THORACOSCOPIC PRODUCTION OF A COX MAZE III LESION SET 07-22-2010
114. 20100184092 Methods and Compositions for Detecting Receptor-Ligand Interactions in Single Cells 07-22-2010
115. 20100184033 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY 07-22-2010
116. 20100184012 METHODS AND DEVICES FOR IMAGING AND MANIPULATING BIOLOGICAL SAMPLES 07-22-2010
117. 20100179574 SYNTHETIC CHORD - devices and methods for using the same for connecting tissues are provided 07-15-2010
118. 20100178307 TRANSDERMAL ANTI-DEMENTIA ACTIVE AGENT FORMULATIONS AND METHODS FOR USING THE SAME 07-15-2010
119. 20100173860 Purifications of Pomegranate Ellagitannins and Their Uses Thereof 07-08-2010
120. 20100173427 LEVETIRACETAM IMMUNOASSAYS - Methods compositions and kits are disclosed directed at levetiracetam derivatives immunogens 07-08-2010
121. 20100173349 Cellular Libraries of Peptide Sequences (CLiPS) and Methods of Using the Same 07-08-2010
122. 20100172941 Adjuvant Compositions and Methods of Use 07-08-2010
123. 20100172913 FIBROSIS INHIBITOR - objective of the present invention is to provide methods for treating or preventing fibrotic diseases 07-08-2010
124. 20100172883 METHODS OF GENERATING CARDIOMYOCYTES - from a cell other than a cardiomyocyte 07-08-2010
125. 20100172871 Muller Cell Specific Gene Therapy - methods and compositions for the treatment of disease of the eye such as retinitis pigmentosa and glaucoma 07-08-2010
126. 20100168225 Small-Molecule Hepatitis C Virus (HCV) NS3/4A Serine Protease Inhibitors 07-01-2010
127. 20100168058 NOVEL ANTAGONISTS OF THE TOLL-LIKE RECEPTOR 4 07-01-2010
128. 20100166773 THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS 07-01-2010
129. 20100164691 DEVICE, METHOD AND SYSTEM FOR MONITORING, TRACKING AND THEFT PROTECTING OF OBJECTS TO BE SECURED 07-01-2010
130. 20100163583 Holder for Containing and Dispensing a Fluid 07-01-2010
131. 20100160262 COMPOSITIONS AND METHODS FOR MODULATING SIRTUIN ACTIVITY 06-24-2010
132. 20100158974 COATED IMPLANT - implant or part thereof coated with a wax or a resin 06-24-2010
133. 20100155668 SEMICONDUCTOR NANOCRYSTAL PROBES FOR BIOLOGICAL APPLICATIONS AND PROCESS FOR MAKING AND USING SUCH PROBES 06-24-2010
134. 20100151590 DIAGNOSIS AND TREATMENT OF INFECTIOUS DISEASES THROUGH INDEL-DIFFERENTIATED PROTEINS 06-17-2010
135. 20100147311 Apparatus and Method for Selective Ventilation of a Patient 06-17-2010
136. 20100147055 METHOD AND SYSTEM FOR MEASURING A RHEOLOGICAL TRANSITION LEVEL 06-17-2010
137. 20100146268 Method for Saving a File - method for storing a file originating from a source location at a target location 06-10-2010
138. 20100144900 Stereo Photo Hydrofel, a Process of Making Said Stereo Photo Hydrogel, Polymers for Use in Making Such Hydrogel and a Pharmaceutical Comprising Said Polymers 06-10-2010
139. 20100144691 Treatment of Female Fertility Conditions Through Modulation of the Autonomic Nervous System 06-10-2010
140. 20100144590 BIOCOMPATIBLE PHASE INVERTABLE PROTEINACEOUS COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME 06-10-2010
141. 20100143931 Stable Metal/Conductive Polymer Composite Colloids and Methods for Making and Using the Same 06-10-2010
142. 20100143480 TRICALCIUM PHOSPHATE COARSE PARTICLE COMPOSITIONS AND METHODS FOR MAKING THE SAME 06-10-2010
143. 20100137200 METHODS FOR TREATMENT OF GROWTH DISORDERS 06-03-2010
144. 20100136557 Methods and Compositions for Isolating Nucleic Acid Sequence Variants 06-03-2010
145. 20100135886 Treatment of Talc in a Solvent - process for the treatment of talc comprising the steps of providing a talc having a first brightness value B1 06-03-2010
146. 20100133772 MOTORCYCLE - four wheeled motorcycle vehicle comprising: a frame two pairs of two spaced apart swing arms pivotally mounted thereon at both ends on 06-03-2010
147. 20100133271 DEVICE FOR PLACING AND CONTAINING SOILED OBJECTS THEREIN 06-03-2010
148. 20100132699 BURST VALVE FOR AEROSOL DEVICE - Aerosol dispensing devices and methods for using the same for administering aerosolized drugs to a subject are provided 06-03-2010
149. 20100130577 PYRAZALONE DERIVATIVE FORMULATIONS - Pyrazolone derivative formulations are provided 05-27-2010
150. 20100130440 ANTIVIRAL NUCLEOSIDES - Disclosed are nucleosides which are useful in diagnosing and treating viral infections for example 05-27-2010
151. 20100130383 METHODS AND COMPOSITIONS IN PARTICLE-BASED DETECTION OF TARGET MOLECULES USING COVALENT BOND FORMING REACTIVE PAIRS 05-27-2010
152. 20100129915 METHODS FOR INDUCING CARDIOMYOGENESIS - methods of inducing cardiomyogenesis and expansion of cardiac progenitors in a population of stem cells or 05-27-2010
153. 20100129903 PITX3 EXPRESSION PROMOTERS - Isolated polynucleotides comprising a PITX3 promoter are provided where a PITX3 regulatory element is operably joined to a 05-27-2010
154. 20100129819 METHODS AND COMPOSITIONS IN PARTICLE-BASED DETECTION OF TARGET MOLECULES USING LINKING MOLECULES 05-27-2010
155. 20100129429 INHIBITION OF AUTOPHAGY GENES IN CANCER CHEMOTHERAPY 05-27-2010
156. 20100122794 METHOD FOR COUPLING TWO ADJACENT HEAT EXCHANGERS AND COUPLING UNIT FOR USE THEREIN 05-20-2010
157. 20100121219 Mouth Cell Collection Device with Mechanically Rinsible Scoop 05-13-2010
158. 20100121155 Minimally Invasive Tissue Modification Systems With Integrated Visualization 05-13-2010
159. 20100121142 Minimally Invasive Imaging Device - Aspects of the invention include minimally invasive internal target tissue site imaging devices 05-13-2010
160. 20100121139 Minimally Invasive Imaging Systems - Aspects of the invention include minimally invasive imaging system 05-13-2010
161. 20100120738 ANTI-APOPTOTIC BENZODIAZEPINE RECEPTOR LIGAND INHIBITORS 05-13-2010
162. 20100120021 HPV E6, E7 MRNA Assay and Methods of Use Thereof 05-13-2010
163. 20100119515 PHARMACEUTICAL COMPOSITIONS AND METHODS USEFUL FOR MODULATING ANGIOGENESIS, INHIBITING METASTASIS AND TUMOR FIBROSIS, AND ASSESSING THE MALIGNANCY OF COLON CANCER TUMORS 05-13-2010
164. 20100119482 Treatment of Conditions Through Modulation of the Autonomic Nervous System During at Least One Predetermined Menstrual Cycle Phase 05-13-2010
165. 20100113303 Polypeptide Display Libraries and Methods of Making and Using Thereof 05-06-2010
166. 20100112686 SHORT HAIRPIN RNAS FOR INHIBITION OF GENE EXPRESSION 05-06-2010
167. 20100109361 GRIPPER FOR OBJECTS - device for engaging objects such as heat exchangers of varying sizes 05-06-2010
168. 20100104603 USE OF STAPHYLOCOCCAL SUPERANTIGEN-LIKE PROTEIN 5 (SSL5) IN MEDICINE 04-29-2010
169. 20100100975 SILK PROTEINS - , as well as nucleic acids encoding these proteins 04-22-2010
170. 20100100456 CELL ONTOGENY INFORMATION SYSTEMS AND METHODS OF USING THE SAME 04-22-2010
171. 20100099169 GENETIC SELECTION SYSTEM FOR IMPROVING RECOMBINANT PROTEIN EXPRESSION 04-22-2010
172. 20100098639 Compositions and Methods for Convection Enhanced Delivery of High Molecular Weight Neurotherapeutics 04-22-2010
173. 20100094410 COATED IMPLANT - implant or a part thereof coated with polylactide 04-15-2010
174. 20100093832 MODULATION OF INSULIN LIKE GROWTH FACTOR I RECEPTOR EXPRESSION IN CANCER 04-15-2010
175. 20100093660 ANTI-TUMOR COMPOSITION COMPRISING TISSUE-ACCUMULATING CHITOSAN GEL 04-15-2010
176. 20100093613 METHODS FOR IDENTIFYING AGENTS AND THEIR USE FOR THE PREVENTION OR STABILIZATION OF FIBROSIS 04-15-2010
177. 20100092955 GEL MICRODROP COMPOSITION AND METHOD OF USING THE SAME 04-15-2010
178. 20100092450 Use of Hyaluronidase for the Prevention or Treatment of Arterial Hypertension or Cardiac Insufficiency 04-15-2010
179. 20100087394 Compositions Containing Betaine and Hydrophobic Silica 04-08-2010
180. 20100086606 Active Agent Loaded Uniform, Rigid, Spherical, Nanoporous Calcium Phosphate Particles and Methods of Making and Using the Same 04-08-2010
181. 20100081905 ANALYTE SENSORS COMPRISING LEVELING AGENTS 04-01-2010
182. 20100081201 Olig1 mini-promoters - Isolated polynucleotides comprising an OLIG1 promoter are provided where an OLIG1 regulatory element is operably joined to an 04-01-2010
183. 20100081153 CANCER ASSOCIATED PROTEIN KINASES AND THEIR USES 04-01-2010
184. 20100080842 TRANSDERMAL EXTENDED-DELIVERY DONEPEZIL COMPOSITIONS AND METHODS FOR USING THE SAME 04-01-2010
185. 20100080794 MUTANT POLYPEPTIDE HAVING EFFECTOR FUNCTION 04-01-2010
186. 20100069611 CYTOLETHAL DISTENDING TOXINS AND DETECTION OF CAMPYLOBACTER BACTERIA USING THE SAME AS A TARGET 03-18-2010
187. 20100068728 POLYSACCHARIDE DERIVATIVES AND USES IN INDUCTION OF AN IMMUNE RESPONSE 03-18-2010
188. 20100068158 Cleansing Composition - comprising an anti-microbial agent and a sulphur binding and/or oxidising agent 03-18-2010
189. 20100047880 PRODUCTION OF N-ACYLATED SULPHUR-CONTAINING AMINO ACIDS WITH MICROORGANISMS HAVING ENHANCED N-ACYLTRANSFERASE ENZYMATIC ACTIVITY 02-25-2010
190. 20100047879 PRODUCING METHIONINE WITHOUT N-ACYL-METHIONINE 02-25-2010
191. 20100047797 CYTOLETHAL DISTENDING TOXINS AND DETECTION OF CAMPYLOBACTER BACTERIA USING THE SAME AS A TARGET 02-25-2010
192. 20100044232 Particle-Based Microfluidic Device for Providing High Magnetic Field Gradients 02-25-2010
193. 20100041112 Production of Biodiesel - feedstock and biodiesel 02-18-2010
194. 20100040620 ANTI-CANCER ANTIBODIES AGAINST LEWISy AND LEWISb ANTIGENS 02-18-2010
195. 20100040612 METHODS AND COMPOSITIONS FOR REDUCING AMYLOID BETA LEVELS 02-18-2010
196. 20100035763 METHOD OF SCREENING SINGLE CELLS FOR THE PRODUCTION OF BIOLOGICALLY ACTIVE AGENTS 02-11-2010
197. 20100034752 INHALANT FORMULATIONS COMPRISING A BISPHOSPHONATE AND A PYRAZOLONE DERIVATIVE AND METHODS FOR USING THE SAME 02-11-2010
198. 20100030052 ANALYTE SENSORS COMPRISING PLASTICIZERS - method and analyte-measurement device adapted to determine the concentration of an analyte in a fluid from a 02-04-2010
199. 20100029913 BIOCOMPATIBLE PHASE INVERTIBLE PROTEINACEOUS COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME 02-04-2010
200. 20100029574 COSMETIC COMPOSITIONS - The present invention generally features novel cosmetic skin and hair care compositions for enhancing the appearance of 02-04-2010
201. 20100029501 METHOD OF IDENTIFYING MICRO-RNA TARGETS - methods of identifying an mRNA target of a microRNA 02-04-2010
202. 20100029004 DURATION AND ENVIRONMENTAL MONITORING COMPOSITIONS, DEVICES METHODS FOR PREPARATION AND SYSTEMS 02-04-2010
203. 20100028946 FUSION PARTNER CELLS - that enable production of heterohybridomas even from cells of species other than mouse were produced by fusing myeloma cells 02-04-2010
204. 20100022824 TISSUE MODIFICATION DEVICES AND METHODS OF USING THE SAME 01-28-2010
205. 20100022646 METHOD OF NEUTRALISING ORGANOBORONATES WITH ACIDS 01-28-2010
206. 20100022624 Methods of Treating Smooth Muscle Cell Disorders 01-28-2010
207. 20100021440 USE OF TROPOELASTIN FOR REPAIR OR RESTORATION OF TISSUE 01-28-2010
208. 20100021361 METHODS AND SYSTEMS FOR SELECTIVELY SEPARATING CO2 FROM A MULTI-COMPONENT GASEOUS STREAM 01-28-2010
209. 20100015666 ISOTHERMAL DNA AMPLIFICATION - for amplification of one or more polynucleotides by multi-staged linear amplifications using one or more RNA polymerases 01-21-2010
210. 20100012018 CO-TOPO-POLYMERIC COMPOSITIONS, DEVICES AND SYSTEMS FOR CONTROLLING THRESHOLD AND DELAY ACTIVATION SENSITIVITIES 01-21-2010
211. 20090326057 THERAPEUTIC USES OF UROLITHINS - The subject invention is drawn to ellagitannin metabolites that find use in treating or preventing a neoplastic disease 12-31-2009
212. 20090325969 METHOTREXATE ADJUVANTS TO REDUCE TOXICITY AND METHODS FOR USING THE SAME 12-31-2009
213. 20090325893 DOXORUBICIN ADJUVANTS TO REDUCE TOXICITY AND METHODS FOR USING THE SAME 12-31-2009
214. 20090325869 SYNTHETIC REGULATORS OF FERRITIN PROTEIN NANOCAGE PORES AND METHODS OF USE THEREOF 12-31-2009
215. 20090325245 Ethanolamine Production by Fermentation - bacterium and a method for the biological production of ethanolamine from a fermentable carbon source 12-31-2009
216. 20090325170 MEANS AND METHODS FOR DIAGNOSING AND/OR TREATING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE 12-31-2009
217. 20090324606 THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS 12-31-2009
218. 20090318898 VARIABLE DIAMETER SURGICAL DRAINS AND SHEATHS 12-24-2009
219. 20090317002 INTRA-OPERATIVE SYSTEM FOR IDENTIFYING AND TRACKING SURGICAL SHARP OBJECTS, INSTRUMENTS, AND SPONGES 12-24-2009
220. 20090314372 FLUID FLOW REGULATING DEVICE - fluid flow regulating mechanism designed particularly for use in connection with aerosolized drug delivery devices is 12-24-2009
221. 20090312422 METHOD OF MODULATING CELLULAR ACTIVITY AND AGENTS USEFUL FOR SAME 12-17-2009
222. 20090311789 METHOD FOR PREPARING DIFFERENTIATED AVIAN CELLS AND GENES INVOLVED IN MAINTAINING PLURIPOTENCY 12-17-2009
223. 20090311682 COMBINATION OF AVIAN CELL MARKERS - novel combination of avian cell markers which make it possible to characterize the said cells according to their 12-17-2009
224. 20090311559 SYSTEMS AND METHODS FOR ELECTROCHEMICAL POWER GENERATION 12-17-2009
225. 20090311334 MUCOSAL IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID - POLYCYTIDILIC ACID BASED ADJUVANT 12-17-2009
226. 20090311230 SYNTHETIC CATALYTIC FREE RADICAL SCAVENGERS USEFUL AS ANTIOXIDANTS FOR PREVENTION AND THERAPY OF DISEASE 12-17-2009
227. 20090311222 TRANSPLANTATION OF NEURAL CELLS - Restoration or increase of inhibitory interneuron function in vivo is achieved by transplantation of MGE cells into 12-17-2009
228. 20090307791 CALCIUM-ACTIVATED CHLORIDE CHANNEL AND METHODS OF USE THEREOF 12-10-2009
229. 20090306131 CELL LINES WITH LATENT IMMUNODEFICIENCY VIRUS AND METHODS OF USE THEREOF 12-10-2009
230. 20090304769 METHODS FOR IDENTIFYING AGENTS AND THEIR USE FOR THE PREVENTION OF RESTENOSIS 12-10-2009
231. 20090304754 Pegylated glutenase polypeptides - Glutenase proteins, such as prolyl endopeptidases, are stabilized by covalent PEG modification 12-10-2009
232. 20090304719 ACTIVATABLE BINDING POLYPEPTIDES AND METHODS OF IDENTIFICATION AND USE THEREOF 12-10-2009
233. 20090304715 MODIFIED ANTIBODIES WITH ENHANCED BIOLOGICAL ACTIVITIES 12-10-2009
234. 20090304695 METHODS FOR TREATING CANCER BY INHIBITING WNT SIGNALING 12-10-2009
235. 20090302067 DEVICE FOR METERED DISPENSING OF PASTY MASS, AND A CONTAINER THEREFOR 12-10-2009
236. 20090302063 Dosing Device for a Fluid - device for dosed dispensing of a quantity of fluid from a container comprising:--a dosing member which is in fluid 12-10-2009
237. 20090299447 DEPLOYABLE EPICARDIAL ELECTRODE AND SENSOR ARRAY 12-03-2009
238. 20090299445 SENSOR-ASSISTED CATHETER-BASED PROCEDURES 12-03-2009
239. 20090298921 METHODS AND COMPOSITIONS FOR USE IN HOMOLOGOUS RECOMBINATION 12-03-2009
240. 20090297590 KETOTIFEN TRANSDERMAL DRUG DELIVERY SYSTEMS AND METHODS FOR TREATING OPHTHALMIC DISEASE 12-03-2009
241. 20090297537 Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level 12-03-2009
242. 20090291140 TREATMENT OF DYSMENORRHEA VIA TRANSDERMAL ADMINISTRATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 11-26-2009
243. 20090291127 TRANSDERMAL ANTI-DEMENTIA ACTIVE AGENT FORMULATIONS AND METHODS FOR USING THE SAME 11-26-2009
244. 20090286832 NARCOTIC EMULSION FORMULATIONS FOR TREATMENT OF SURGICAL PAIN 11-19-2009
245. 20090286732 COMPOUNDS FOR DELIVERY OF THERAPEUTIC AND IMAGING MOIETIES TO NERVE CELLS 11-19-2009
246. 20090281285 BINDING MEMBER WHICH BINDS TO BOTH LEWIS-Y AND LEWIS-B HAPTENS, AND ITS USE FOR TREATING CANCER 11-12-2009
247. 20090280992 MULTI-WELL SYSTEM - is described which is comprised of a tray comprising a plurality of wells which may include thousands 11-12-2009
248. 20090280568 S100B mini-promoters - Isolated polynucleotides comprising an S100B promoter are provided where an S100B regulatory element is operably joined to an 11-12-2009
249. 20090280555 ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE 11-12-2009
250. 20090280112 INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS 11-12-2009
251. 20090275087 ASYMMETRIC ADAPTER LIBRARY CONSTRUCTION - methods and compositions for asymmetrically tagging a nucleic acid fragment using asymmetric adapters 11-05-2009
252. 20090274754 DUAL ACTION, INHALED FORMULATIONS PROVIDING BOTH AN IMMEDIATE AND SUSTAINED RELEASE PROFILE 11-05-2009
253. 20090274677 ANTIOXIDANT FOR USE IN COSMETIC, MEDICATED AND PHARMACEUTICAL PREPARATIONS 11-05-2009
254. 20090270323 METHODS FOR TREATMENT OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY 10-29-2009
255. 20090269396 DUAL ACTION, INHALED FORMULATIONS PROVIDING BOTH AN IMMEDIATE AND SUSTAINED RELEASE PROFILE 10-29-2009
256. 20090269357 ANTI-TNFalpha ANTIBODY - antibody that binds TNF 10-29-2009
257. 20090264502 COMPOSITIONS AND THEIR USES DIRECTED TO HSP27 10-22-2009
258. 20090264359 FPLR-1 INHIBITORS FOR USE IN DISEASES INVOLVING AMYLOID-INDUCED INFLAMMATORY EVENTS (FLIPR AND FLIPR-LIKE) AND IMMUNECOMPLEX-MEDIATED DISEASES 10-22-2009
259. 20090264344 RETROCYCLINS: ANTIVIRAL AND ANTIMICROBIAL PEPTIDES 10-22-2009
260. 20090263875 METHODS OF GENERATING PROTEIN VARIANTS WITH ALTERED FUNCTION 10-22-2009
261. 20090263670 Method of Fabricating Lipid Bilayer Membranes on Solid Supports 10-22-2009
262. 20090263513 COSMETIC SKIN LIGHTENING FORMULATION - The present invention features novel cosmetic skin care compositions for lightening hyperpigmentation 10-22-2009
263. 20090263358 METHOD FOR TREATING MULTIPLE MYELOMA - methods for the treatment of multiple myeloma 10-22-2009
264. 20090258354 Methods for DNA Length and Sequence Determination 10-15-2009
265. 20090253211 SEMICONDUCTOR NANOCRYSTAL PROBES FOR BIOLOGICAL APPLICATIONS AND PROCESS FOR MAKING AND USING SUCH PROBES 10-08-2009
266. 20090253144 METHODS OF ASSESSING DNA DAMAGE - This invention relates to the finding that HP1 10-08-2009
267. 20090246870 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING NANOG 10-01-2009
268. 20090246190 ANTI-VEGF ANTIBODY - antibody is provided 10-01-2009
269. 20090246175 THERAPEUTIC USE OF SCIN, A STAPHYLOCOCCAL COMPLEMENT INHIBITOR IN INFLAMMATORY DISEASES 10-01-2009
270. 20090246150 ANTIMICROBIAL COMPOSITION - novel antimicrobial composition comprising a peptide which can be obtained from the milk protein casein or chemically 10-01-2009
271. 20090241950 METHOD OF TREATING DIABETES MELLITUS IN A PATIENT 10-01-2009
272. 20090239219 TELOMERASE EXPRESSION REPRESSOR PROTEINS AND METHODS OF USING THE SAME 09-24-2009
273. 20090233267 Methylated Tat Polypeptides and Methods of Use Thereof 09-17-2009
274. 20090232779 OLIGODENDROCYTES DERIVED FROM HUMAN EMBRYONIC STEM CELLS FOR REMYELINATION AND TREATMENT OF SPINAL CORD INJURY 09-17-2009
275. 20090231589 Stable Metal/Conductive Polymer Composite Colloids and Methods for Making and Using the Same 09-17-2009
276. 20090221428 Methods of Genome-Wide Location Analysis in Stem Cells 09-03-2009
277. 20090221097 METHOD OR AGENT FOR INHIBITING THE FUNCTION OF EFFLUX PUMP OF PSEUDOMONAS AERUGINOSA 09-03-2009
278. 20090220951 Methods and compositions for classifying bacillus bacteria 09-03-2009
279. 20090220945 HPV E6, E7 mRNA ASSAY AND METHODS OF USE THEREOF 09-03-2009
280. 20090220554 Transglutaminase Inhibitors and Methods of Use Thereof 09-03-2009
281. 20090220415 DIAGNOSTIC SYSTEM FOR THE DETECTION OF SKIN CANCER 09-03-2009
282. 20090215708 Treatment of Sexual Dysfunction with Proton Pump Agonists 08-27-2009
283. 20090215645 Cell-Based Microarrays And Methods Of Use 08-27-2009
284. 20090215083 SELECTING, CULTURING AND CREATING LINEAGE COMMITTED HEMATOPOIETIC STEM CELLS 08-27-2009
285. 20090214582 METHODS FOR IDENTIFYING AN EPITOPE OF A POLYPEPTIDE, CHLAMYDIAL ANTIGENIC POLYPEPTIDES IDENTIFIED THEREBY, AND METHODS OF USE THEREOF 08-27-2009
286. 20090212074 Dispenser with improved supply-closing means 08-27-2009
287. 20090208932 Methods Of Detecting An Analyte In A Sample 08-20-2009
288. 20090206080 Universal Lids and Methods for Making and Using the Same 08-20-2009
289. 20090205057 MITE COMPOSITION COMPRISING GLYCYPHAGIDAE AND PHYTOSEIID MITES, USE THEREOF, METHOD FOR REARING A PHYTOSEIID PREDATORY MITE, REARING SYSTEM FOR REARING SAID PHYTOSEIID PREDATORY MITE AND METHODS FOR BIOLOGICAL PEST CONTROL ON A CROP 08-13-2009
290. 20090205056 METHOD OF SCREENING FOR MODULATORS OF MAP3K11 IN LIVER CANCER CELLS 08-13-2009
291. 20090202564 METHODS OF ISOLATING STEM CELLS - The present inventors discovered for the first time that labeling cell nuclei makes it possible to efficiently isolate 08-13-2009
292. 20090202558 TNFalpha-NEUTRALIZING ANTIBODIES - The invention provides monoclonal antibodies that neutralize TNF 08-13-2009
293. 20090202539 METHOD FOR TREATING CANCER USING ANTI-WNT2 MONOCLONAL ANTIBODIES AND siRNA 08-13-2009
294. 20090202517 AGENTS FOR IMPROVING INFLAMMATORY BOWEL DISEASE 08-13-2009
295. 20090202515 AGENTS FOR SUPPRESSING NEURAL FIBROTIC DEGENERATION 08-13-2009
296. 20090202514 AGENTS FOR IMPROVING CHRONIC OBSTRUCTIVE PULMONARY DISEASES 08-13-2009
297. 20090202440 MODEL ANIMAL OF DENDRITIC CELL IMMUNORECEPTOR GENE KNOCKOUT DISEASE 08-13-2009
298. 20090202437 Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases 08-13-2009
299. 20090197868 5ht2c receptor modulator compositions and methods of use 08-06-2009
300. 20090197833 Silicon Containing Compounds Having Selective Cox-2 Inhibitory Activity and Methods of Making and Using the Same 08-06-2009
301. 20090197281 METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC IMMUNE DISEASES 08-06-2009
302. 20090197221 DENTAL BONDING COMPOSITIONS AND METHODS USEFUL IN INHIBITION OF MICROLEAKAGE IN RESIN-BONDED DENTIN 08-06-2009
303. 20090191567 SEMICONDUCTOR NANOCRYSTAL PROBES FOR BIOLOGICAL APPLICATIONS AND PROCESS FOR MAKING AND USING SUCH PROBES 07-30-2009
304. 20090188941 PIPING BAG FOR APPLYING FOODSTUFFS TO A SUBSTRATE 07-30-2009
305. 20090187131 METHODS AND DEVICES FOR RETRIEVAL OF A MEDICAL AGENT FROM A PHYSIOLOGICAL EFFERENT FLUID COLLECTION SITE 07-23-2009
306. 20090187101 METHOD AND APPARATUS TO REMOVE SUBSTANCES FROM VESSELS OF THE HEART AND OTHER PARTS OF THE BODY TO MINIMIZE OR AVOID RENAL OR OTHER HARM OR DYSFUNCTION 07-23-2009
307. 20090186414 Methods of Generating Cardiomyocytes and Cardiac Progenitors and Compositions 07-23-2009
308. 20090186013 INORGANIC MATERIALS FOR HEMOSTATIC MODULATION AND THERAPEUTIC WOUND HEALING 07-23-2009
309. 20090182014 INSECTICIDAL COMPOSITIONS COMPRISING COMPOUNDS HAVING INHIBITORY ACTIVITY VERSUS ACYL COA: CHOLESTEROL ACYLTRANSFERASE OR SALTS THEREOF AS EFFECTIVE INGREDIENTS 07-16-2009
310. 20090175902 Immunogenic Substances Comprising A Polyinosinic Acid-Polycytidilic Acid Based Adjuvant 07-09-2009
311. 20090170719 SUPERIOR HYBRIDIZATION PROBES AND METHODS FOR THEIR USE IN DETECTION OF POLYNUCLEOTIDE TARGETS 07-02-2009
312. 20090170718 High-stringency screening of target-binding partners using a microfludic device 07-02-2009
313. 20090163413 DENTAL PRODUCTS COMPRISING BONE GROWTH ENHANCING PEPTIDE 06-25-2009
314. 20090162369 SYNTHETIC CHIMERIC PEPTIDES - generally to chimeric peptides comprising one or more protective epitopes in a conformation enabling immunological 06-25-2009
315. 20090156457 METHODS AND MEANS FOR SCREENING FOR RHOMBOID ACTIVITY 06-18-2009
316. 20090155898 METHOD FOR PRODUCING DENDRITIC CELLS - Disclosed are embryonic stem cell-derived dendritic cells genetically modified immature dendritic cells capable 06-18-2009
317. 20090155867 Glycolic Acid Production by Fermentation from Renewable Resources 06-18-2009
318. 20090155824 METHODS FOR ANTIBODY ENGINEERING - method for identifying positions of an antibody that can be modified without significantly reducing the binding 06-18-2009
319. 20090151012 Animal Model Having a Chimeric Human Liver and Susceptible to Human Hepatitis C Virus Infection 06-11-2009
320. 20090149780 Method and Apparatus for Physiological Testing 06-11-2009
321. 20090143584 TRANSITION METAL COMPLEXES WITH (PYRIDYL)IMIDAZOLE LIGANDS 06-04-2009
322. 20090143500 BIOCOMPATIBLE PHASE INVERTIBLE PROTEINACEOUS COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME 06-04-2009
323. 20090143451 COMPOUNDS THAT INCREASE TELOMERASE REVERSE TRANSCRIPTASE (TERT) EXPRESSION AND METHODS FOR USING THE SAME 06-04-2009
324. 20090143240 Novel Methods for Genome-Wide Location Analysis 06-04-2009
325. 20090142807 FUSION PARTNER FOR PRODUCTION OF MONOCLONAL RABBIT ANTIBODIES 06-04-2009
326. 20090137889 Subcutaneous Glucose Electrode - small diameter flexible electrode designed for subcutaneous in vivo amperometric monitoring of glucose is described 05-28-2009
327. 20090137501 Resistance Genes - Genes involved in immune resistance to infection and uses thereof are described 05-28-2009
328. 20090136456 METHODS OF TREATING NEURODEGENERATIVE DISORDERS 05-28-2009
329. 20090131767 Body-associated fluid transport structure evaluation devices 05-21-2009
330. 20090131496 PYRAZOLONE DERIVATIVE EMULSION FORMULATIONS 05-21-2009
331. 20090131347 IMMUNIZATION-FREE METHODS FOR TREATING ANTIGEN-STIMULATED INFLAMMATION IN A MAMMALIAN HOST AND SHIFTING THE HOST'S ANTIGEN IMMUNE RESPONSIVENESS TO A TH1 PHENOTYPE 05-21-2009
332. 20090131265 BIOMARKERS FOR NEURODEGENERATIVE DISORDERS 05-21-2009
333. 20090130710 Enhancing vegetative protein production in transgenic plants using seed specific promoters 05-21-2009
334. 20090130030 Plural Activating Optical Change Toothpastes, Stimuli and Elements 05-21-2009
335. 20090124547 COMPOUNDS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC MOIETIES TO NERVE CELLS 05-14-2009
336. 20090123481 THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS 05-14-2009
337. 20090123465 ASSESSMENT OF CARDIAC HEALTH AND THROMBOTIC RISK IN A PATIENT 05-14-2009
338. 20090118459 BRANCHED BIODEGRADABLE POLYMERS, A MACROMONOMER, PROCESSES FOR THE PREPARATION OF SAME, AND THEIR USE 05-07-2009
339. 20090118133 BIOLOGICAL DATASET PROFILING OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR INFLAMMATION 05-07-2009
340. 20090117093 GRANULYSIN PEPTIDES AND METHODS OF USE THEREOF 05-07-2009
341. 20090110576 System of bellows and co-acting part - comprising a co-acting part which comprises a stiff outer wall 04-30-2009
342. 20090105187 METHODS OF TREATING LENTIVIRUS INFECTION 04-23-2009
343. 20090104707 ANALYTE DETECTION WITH MAGNETIC SENSORS - Methods for analyte detection with magnetic sensors are provided 04-23-2009
344. 20090104133 Methods of Moisturizing the Skin and Killing Microorganisms Thereon 04-23-2009
345. 20090101878 Closing Part and Gate Provided with Such a Closing Part 04-23-2009
346. 20090101648 CONTAINER AND METHOD FOR PRODUCING SUCH A CONTAINER 04-23-2009
347. 20090099032 HIGHLY SENSITIVE PROTEOMIC ANALYSIS METHODS, AND KITS AND SYSTEMS FOR PRACTICING THE SAME 04-16-2009
348. 20090097022 DISCOVERY TOOL WITH INTEGRATED MICROFLUIDIC BIOMARKER OPTICAL DETECTION ARRAY DEVICE AND METHODS FOR USE 04-16-2009
349. 20090095642 TRANSITION METAL COMPLEXES WITH PYRIDYL-IMIDAZOLE LIGANDS 04-16-2009
350. 20090095290 TRACHEAL TUBE WITH COLORIMETRIC CO2 INDICATOR 04-16-2009
351. 20090093539 ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE THEREOF 04-09-2009
352. 20090090625 BIOSENSOR ELECTRODE MEDIATORS FOR REGENERATION OF COFACTORS 04-09-2009
353. 20090090624 BIOSENSOR ELECTRODE MEDIATORS FOR REGENERATION OF COFACTORS 04-09-2009
354. 20090088417 VANILLOID RECEPTOR ANTAGONIST FOR PREVENTION AND TREATMENT OF DRUG DEPENDENCE AND ADDICTION 04-02-2009
355. 20090087907 Compositions and Methods for Growth of Pluripotent Cells 04-02-2009
356. 20090087906 NOVEL CELL-BASED ASSAYS FOR G-PROTEIN-COUPLED RECEPTOR-MEDIATED ACTIVITIES 04-02-2009
357. 20090082431 MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2 MODULATORS AND METHODS OF USE THEREOF 03-26-2009
358. 20090082271 AGENTS THAT REDUCE APOE-INDUCED IMPAIRMENT OF MITOCHONDRIA AND METHODS OF USE THEREOF 03-26-2009
359. 20090081737 METHODS AND COMPOSITIONS FOR REDUCING THE COMPLEXITY OF A NUCLEIC ACID SAMPLE 03-26-2009
360. 20090078586 Small Volume In Vitro Analyte Sensor - sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than 03-26-2009
361. 20090078014 AGRICULTURAL COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME 03-26-2009
362. 20090076254 NON-ENDOGENOUS, CONSTITUTIVELY ACTIVATED HUMAN SEROTONIN RECEPTORS AND SMALL MOLECULE MODULATORS THEREOF 03-19-2009
363. 20090074876 PEPTIDE COMPOSITION AND A METHOD OF PROMOTING CARTILAGE FORMATION 03-19-2009
364. 20090074816 TISSUE TARGETED ANTIGENIC ACTIVATION OF THE IMMUNE RESPONSE TO CANCERS 03-19-2009
365. 20090074688 Antimicrobial Lotion Compositions - Methods of using absorption enhancer as a component of skin care compositions for moisturizing and protecting the 03-19-2009
366. 20090068738 COMPOSITIONS AND METHODS FOR MODIFICATION OF BIOMOLECULES 03-12-2009
367. 20090062375 METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASES 03-05-2009
368. 20090062201 INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES 03-05-2009
369. 20090060892 AGENTS FOR SUPPRESSING HEPATIC FIBROSIS - hepatic fibrosis-suppressing agents that are suitable for treating or preventing fibrotic liver diseases such 03-05-2009
370. 20090054812 LANCING DEVICE - is adapted for use in firing a lancet into the skin of a patient to acquire a blood sample and 02-26-2009
371. 20090054767 SURGICAL METHOD AND APPARATUS FOR IDENTIFICATION OF FLUORESCENCE 02-26-2009
372. 20090054331 HIGH TEMPERATURE STABLE PEPTIDE FORMULATION 02-26-2009
373. 20090051901 INTEGRATED MICROFLUIDIC OPTICAL DEVICE FOR SUB-MICRO LITER LIQUID SAMPLE MICROSPECTROSCOPY 02-26-2009
374. 20090050653 Thin-Walled Dosing Device Having An Integrally Moulded Trigger And Spring, And Method For Assembling Same 02-26-2009
375. 20090050140 PORE STRUCTURES FOR REDUCED PRESSURE AEROSOLIZATION 02-26-2009
376. 20090048678 SPINAL DISC ANNULUS AUGMENTATION - Intervertebral disc implants are provided for augmenting the annulus of the disc in a manner to bear at least part of 02-19-2009
377. 20090048552 METHODS AND DEVICES FOR REMOVAL OF A MEDICAL AGENT FROM A PHYSIOLOGICAL EFFERENT FLUID COLLECTION SITE 02-19-2009
378. 20090047329 MESOCELLULAR OXIDE FOAMS AS HEMOSTATIC COMPOSITIONS AND METHODS OF USE 02-19-2009
379. 20090042987 TREATMENT OF NEUROPATHIC PAIN - method of decreasing neuropathic pain in a mammal comprising administering to said mammal an effective amount of 02-12-2009
380. 20090042791 INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES 02-12-2009
381. 20090042184 Method Of Diagnosing Cancer And Reagents Therefor 02-12-2009
382. 20090042183 Use of pcr-based techniques to analyze compositions of botanicals 02-12-2009
383. 20090041757 Bone morphogenetic protein antagonist and uses thereof 02-12-2009
384. 20090041674 TARGETED IRON OXIDE NANPARTICLES - Iron oxide nanoparticles comprising functional groups of the formula --X--NH 02-12-2009
385. 20090039110 Dispenser with Improved Supply-Closing Means 02-12-2009
386. 20090036872 Methods, Systems and Devices for Establising Communication Between Hollow Organs and Tissue Lumens 02-05-2009
387. 20090036769 SPREAD SPECTRUM ELECTRIC TOMOGRAPHY - Methods for locating a sensor element in vivo, e 02-05-2009
388. 20090035394 USE OF DNA-PK INHIBITION TO SENSITISE ATM DEFICIENT CANCERS TO DNA-DAMAGING CANCER THERAPIES 02-05-2009
389. 20090035328 fHbp- AND LPXL1-BASED VESICLE VACCINES FOR BROAD SPECTRUM PROTECTION AGAINST DISEASES CAUSED BY NEISSERIA MENINGITIDIS 02-05-2009
390. 20090035300 IMMUNOMODULATION OF DENDRITIC CELLS - isolated nucleic acid molecule encoding the transcription regulator DC-SCRIPT or a derivative thereof 02-05-2009
391. 20090029915 REGULATION OF MINERAL AND SKELETAL METABOLISM 01-29-2009
392. 20090029391 REAGENTS AND METHODS FOR THE DETERMINATION OF PK/ADME-TOX CHARACTERISTICS OF NEW CHEMICAL ENTITIES AND OF DRUG CANDIDATES 01-29-2009
393. 20090028802 ORGANOLEPTICALLY ACCEPTABLE INDOLE SEROTONIN RECEPTOR AGONIST ORAL DOSAGE FORMULATIONS AND METHODS OF USING THE SAME 01-29-2009
394. 20090024176 METHODS AND DEVICES FOR PRODUCING RESPIRATORY SINUS ARRHYTHMIA 01-22-2009
395. 20090023898 METHODS AND COMPOSITIONS FOR PROTEIN PURIFICATION 01-22-2009
396. 20090023634 REGULATION OF MINERAL AND SKELETAL METABOLISM 01-22-2009
397. 20090023633 REGULATION OF MINERAL AND SKELETAL METABOLISM 01-22-2009
398. 20090022736 Monoclonal Antibodies That Specifically Bind To And Neutralize Bacillus Anthracis Toxin, Compositions, And Methods Of Use 01-22-2009
399. 20090022691 BACTERIAL DELIVERY OF BIOLOGICALLY ACTIVE POLYPEPTIDES 01-22-2009
400. 20090020044 Hydraulic cements comprising carbonate compound compositions 01-22-2009
401. 20090018632 DESIGN-RULE MEDIATED LEAD PLACEMENT - Aspects of the invention include design rule mediated lead placement methods 01-15-2009
402. 20090018425 ANALYTE MONITORING: STABILIZER FOR SUBCUTANEOUS GLUCOSE SENSOR WITH INCORPORATED ANTIGLYCOLYTIC AGENT 01-15-2009
403. 20090018064 REGULATION OF MINERAL AND SKELETAL METABOLISM 01-15-2009
404. 20090017558 APOLIPOPROTEIN E STABLE FOLDING INTERMEDIATE AND METHODS OF USE THEREOF 01-15-2009
405. 20090017022 SULFATASES AND METHODS OF USE THEREOF - Novel sulfatases and polypeptides related thereto, as well as nucleic acid compositions encoding the same, are 01-15-2009
406. 20090014328 Small Volume in vitro Analyte Sensor and Methods of Making 01-15-2009
407. 20090014327 Analyte Test Sensor and Method of Manufacturing the Same 01-15-2009
408. 20090013418 Trophectodermal Cell-Specific Gene Transfer Methods 01-08-2009
409. 20090012186 Mite Composition, Use Thereof, Method for Rearing the Phytoseiid Predatory Mite Amblyseius Sirskii, Rearing System for Rearing Said Phytoseiid Mite and Methods for Biological Pest Control on a Crop 01-08-2009
410. 20090012043 INHIBITORS OF POLYSIALIC ACID DE-N-ACETYLASE AND METHODS FOR USING THE SAME 01-08-2009
411. 20090012022 Hybrid Interfering Rna - molecule comprising a duplex RNA and a single stranded DNA molecule and its use in the ablation of mRNA and in polymerase chain 01-08-2009
412. 20090011449 NO CALIBRATION ANALYTE SENSORS AND METHODS 01-08-2009
413. 20090011415 REGULATION OF NEURONAL EXPRESSION OF APOLIPOPROTEIN E 01-08-2009
414. 20090010949 POLYSIALIC ACID DERIVATIVES, METHODS OF PRODUCTION, AND USES IN ENHANCING CANCER ANTIGEN PRODUCTION AND TARGETING 01-08-2009
415. 20090010944 OLIGOSIALIC ACID DERIVATIVES, METHODS OF MANUFACTURE, AND IMMUNOLOGICAL USES 01-08-2009
416. 20090007904 Device and Method for Generating an Aerosol From a Liquid Formulation and Ensuring Its Sterility 01-08-2009
417. 20090005423 SYSTEMS AND METHODS FOR EFFECTING CESSATION OF TOBACCO USE 01-01-2009
418. 20090005347 DRUG FOR THE TREATMENT OF OSTEONECROSIS AND FOR THE MANAGEMENT OF PATIENTS AT RISK OF DEVELOPING OSTEONECROSIS 01-01-2009
419. 20090005328 METHODS OF MODULATING TUBULIN DEACETYLAST ACTIVITY 01-01-2009
420. 20090004724 METHOD FOR ENHANCING PRODUCTION OF ISOPRENOID COMPOUNDS 01-01-2009
421. 20090004665 METHODS AND COMPOSITIONS FOR ISOLATING NUCLEIC ACID SEQUENCE VARIANTS 01-01-2009
422. 20090004273 Polymeric device for controlled release of active agents 01-01-2009
423. 20090004272 Polymeric devices for controlled release of active agents 01-01-2009
424. 20090004250 DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE 01-01-2009
425. 20090004249 DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE 01-01-2009
426. 20090002683 Small Volume in Vitro Analyte Sensor - sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than 01-01-2009
427. 20090001020 DESALINATION METHODS AND SYSTEMS THAT INCLUDE CARBONATE COMPOUND PRECIPITATION 01-01-2009
428. 20090000961 Small Volume in Vitro Analyte Sensor - sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than 01-01-2009
429. 20090000960 Small Volume in Vitro Analyte Sensor - sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than 01-01-2009
430. 20090000959 ANALYTE DETERMINATION METHODS AND DEVICES 01-01-2009
431. 20080319541 DEVICES AND METHODS FOR REPAIRING CARDIAC VALVES 12-25-2008
432. 20080319008 Compounds Having Activity in Increasing Ion Transport by Mutant-Cftr and Uses Thereof 12-25-2008
433. 20080318984 Compounds Having Activity in Correcting Mutant-Cftr Processing and Uses Thereof 12-25-2008
434. 20080318877 PURIFICATIONS OF POMEGRANATE ELLAGITANNINS AND THEIR USES THEREOF 12-25-2008
435. 20080318851 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex 12-25-2008
436. 20080318802 METHODS AND COMPOSITIONS FOR TAGGING AND IDENTIFYING POLYNUCLEOTIDES 12-25-2008
437. 20080318342 Diagnostic Testing Process and Apparatus Incorporating Controlled Sample Flow 12-25-2008
438. 20080318292 METHODS OF GENERATING PROTEIN VARIANTS - methods of designing and generating polypeptide variants that have altered properties compared to a parent 12-25-2008
439. 20080318261 Small Volume in Vitro Analyte Sensor - sensor designed to determine the concentration of analyte in a sample having a volume of less than about 1 12-25-2008
440. 20080318230 GENE EXPRESSION MARKERS FOR RESPONSE TO EGFR INHIBITOR DRUGS 12-25-2008
441. 20080318225 COMPOSITIONS AND METHODS FOR DETECTING CANCER 12-25-2008
442. 20080317801 Control of Rodents - A particulate mixture for use in the control of rodents which comprises a mixture of a plurality of bait particles and a plurality 12-25-2008
443. 20080316020 RFID ANTENNA FOR IN-BODY DEVICE - RFID antennas for ingestible devices, such as ingestible event markers, are provided 12-25-2008
444. 20080312201 Reduced Toxicity Methotrexate Formulations and Methods for Using the Same 12-18-2008
445. 20080312102 Cytokine Binding Domains - method of generating modified binding moieties comprising a cytokine binding domain consisting of a first FmIII-like domain 12-18-2008
446. 20080311161 Compositions and Methods for Enhanced Gastrointestinal Stability of Oligopeptides and Polypeptides 12-18-2008
447. 20080311041 Water-Soluble, Fluorescent Compounds for Detection of Potassium Ions 12-18-2008
448. 20080306360 LOW PROFILE ANTENNA FOR IN BODY DEVICE - Low profile antennas for ingestible devices, such as ingestible event markers, are provided 12-11-2008
449. 20080302732 INTEGRATED FLUIDICS DEVICES WITH MAGNETIC SORTING 12-11-2008
450. 20080299108 Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue 12-04-2008
451. 20080296513 Integrating ultraviolet exposure detection devices 12-04-2008
452. 20080293054 Hmgcr isoforms in Prediction of Efficacy and Identification of Cholesterol-Modulating Compounds 11-27-2008
453. 20080292579 Polymer-Based Serum Albumin Substitute - This invention provides the use of a polymer comprising a hyperbranched polyether polyol such as hyperbranched 11-27-2008
454. 20080288008 Cardiac Stimulation System and Method - cardiac stimulation assembly includes an energy source coupled to an energy emitter that extends form a delivery 11-20-2008
455. 20080286828 MATERIALS AND METHODS RELATING TO G-PROTEIN COUPLED RECEPTOR OLIGOMERS 11-20-2008
456. 20080286354 COMPOSITION AND THERAPIES FOR HYPERLIPIDAEMIA-ASSOCIATED DISORDERS 11-20-2008
457. 20080283396 Analyte Sensor with Insertion Monitor, and Methods 11-20-2008
458. 20080281260 NEEDLELESS INJECTOR DRUG CAPSULE AND A METHOD FOR FILLING THEREOF 11-13-2008
459. 20080280833 Therapeutic Peptides Derived from Urokinase Plasminogen Activator Receptor 11-13-2008
460. 20080277430 Dosing Head for Dispensing a Fluid From a Container 11-13-2008
461. 20080277294 Small Volume In Vitro Analyte Sensor - sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than 11-13-2008
462. 20080277293 Small Volume In Vitro Analyte Sensor - sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than 11-13-2008
463. 20080277292 Small Volume In Vitro Analyte Sensor - sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than 11-13-2008
464. 20080277291 Small Volume In Vitro Analyte Sensor - sensor designed to determine the amount and concentration of analyte in a sample having a volume of less than 11-13-2008
465. 20080277277 BIOSENSOR MEMBRANES COMPOSED OF POLYMERS CONTAINING HETEROCYCLIC NITROGENS 11-13-2008
466. 20080269586 ELECTROPORATION TO INTERRUPT BLOOD FLOW - method for disrupting blood flow to undesirable tissue such as cells of a cancerous or non-cancerous tumor is 10-30-2008
467. 20080268467 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression 10-30-2008
468. 20080268068 Sparc Promoter Mutations Associated with Drug Resistance, and Methods, Oligonucleotides, Cells and Arrays Associated Therewith 10-30-2008
469. 20080264787 ELECTROCHEMICAL CELL - for detection and quantification of analytes in a liquid sample, particularly a liquid sample having a small volume 10-30-2008
470. 20080264635 Hydrocarbon Recovery Facilitated by in Situ Combustion Utilizing Horizontal Well Pairs 10-30-2008
471. 20080263683 Megsin/Rage/Inos-Overexpressing Renal Disease Model Animals and Methods for Evaluating Compounds Using the Model Animals 10-23-2008
472. 20080262417 NEEDLELESS SYRINGE - device which seeks to ensure that substantially all the particles delivered avoid interaction with the so-called "starting process" 10-23-2008
473. 20080261906 METHODS AND COMPOSITIONS FOR IDENTIFYING ANTI-HCV AGENTS 10-23-2008
474. 20080261819 IN VIVO PRODUCTION OF CYCLIC PEPTIDES FOR INHIBITING PROTEIN-PROTEIN INTERACTION 10-23-2008
475. 20080256661 Reduced Susceptibility Towards Pathogens, In Particular Oomycetes, Such as Downy Mildew In Lettuce and Spinach 10-16-2008
476. 20080255006 MAGNETIC NANOPARTICLES, MAGNETIC DETECTOR ARRAYS, AND METHODS FOR THIER USE IN DETECTING BIOLOGICAL MOLECULES 10-16-2008
477. 20080254052 MOLECULAR DIFFERENCES BETWEEN SPECIES OF THE M. TUBERCULOSIS COMPLEX 10-16-2008
478. 20080250711 Method for Cultivating Plants as Well as a Culture Medium 10-16-2008
479. 20080249058 AGENTS THAT REDUCE NEURONAL OVEREXCITATION 10-09-2008
480. 20080248521 ENHANCED CELL-FREE SYNTHESIS OF ACTIVE PROTEINS CONTAINING DISULFIDE BONDS 10-09-2008
481. 20080248065 Gna1870-Based Vesicle Vaccines for Broad Spectrum Protection Against Diseases Caused by Neisseria Meningitidis 10-09-2008
482. 20080245665 BIOSENSOR - for determining the concentration of an analyte in a biological sample 10-09-2008
483. 20080241820 MULTIPLEX CELLULAR ASSAYS USING DETECTABLE CELL BARCODES 10-02-2008
484. 20080241206 CALCIUM PHOSPHATE CEMENTS COMPRISING AUTOLOGOUS BONE 10-02-2008
485. 20080234559 Analyte Meter Protectors and Methods - Analyte meter protectors, meters that include the same, and methods 09-25-2008
486. 20080233623 GENETICALLY MODIFIED HOST CELLS FOR INCREASED P450 ACTIVITY LEVELS AND METHODS OF USE THEREOF 09-25-2008
487. 20080233617 Process for the Preparation of a Aspartate and Derived Amino Acids Like Lysine, Threonine, Isoleucine, Methionine, or Homoserine Employing Microorganism with Enhanced Isocitrate Lyase and/or Malate Synthase Expression 09-25-2008
488. 20080233581 HISTONE DEACETYLASE AND METHODS OF USE THEREOF 09-25-2008
489. 20080233102 Drug Therapy for Celiac Sprue - Administering an effective dose of a tTGase inhibitor to a Celiac or dermatitis herpetiformis patient reduces the toxic 09-25-2008
490. 20080230563 PRECOMPRESSION SYSTEM FOR A LIQUID DISPENSING DEVICE AND METHOD OF ASSEMBLING SUCH PRECOMPRESSED SYSTEM 09-25-2008
491. 20080230384 LOW VOLUME ELECTROCHEMICAL BIOSENSOR - biosensor in which at least one reagent constitutes a portion of a working electrode a conductive track leading 09-25-2008
492. 20080226707 WNT compositions and methods of use thereof 09-18-2008
493. 20080221605 CUTTING DEVICE POSITIONED VIA CONTROL WIRE TO PERFORM SELECTIVE DISCECTOMY 09-11-2008
494. 20080221225 Genes associated with restenosis - The present invention identifies genes whose gene products are differentially expressed during restenosis 09-11-2008
495. 20080221120 Modulation of Aquaporin in Modulation of Angiogenesis and Cell Migration 09-11-2008
496. 20080220453 Identification and isolation of squamous carcinoma stem cells 09-11-2008
497. 20080220431 Cell fusion method - The invention provides methods for fusing a first cell with a second cell to form a hybrid cell 09-11-2008
498. 20080220406 PHYSIOLOGICALLY ACCEPTABLE AQUEOUS SOLUTIONS AND METHODS FOR THEIR USE 09-11-2008
499. 20080220025 Treating Tumors Using Implants Comprising Combinations of Allogeneic Cells 09-11-2008
500. 20080219956 HLA HOMOZYGOUS CELLS AND METHODS OF USE THEREOF 09-11-2008
501. 20080214995 VISCOUS FORMULATIONS AND THEIR USE IN NEEDLE-FREE INJECTION 09-04-2008
502. 20080214986 GELS WITH PREDETERMINED CONDUCTIVITY USED IN ELECTROPORATION OF TISSUE 09-04-2008
503. 20080214801 CHEMOSELECTIVE LIGATION - The present invention features a chemoselective ligation reaction that can be carried out under physiological conditions 09-04-2008
504. 20080213892 SELF-RENEWAL OF NEURAL STEM CELLS IS PROMOTED BY WNT PROTEINS 09-04-2008
505. 20080213812 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression 09-04-2008
506. 20080213787 Methods and Compositions for Kir Genotyping 09-04-2008
507. 20080213270 NEUROTENSIN AS A MARKER AND THERAPEUTIC TARGET FOR SEPSIS 09-04-2008
508. 20080213239 FATTY ACID FORMULATIONS AND METHODS OF USE THEREOF 09-04-2008
509. 20080208172 Colostomy Pump System - waste evacuator device for evacuating waste products from bodily orifices including stomas and artificial stomas created as a 08-28-2008
510. 20080208068 DYNAMIC POSITIONAL INFORMATION CONSTRAINED HEART MODEL 08-28-2008
511. 20080206571 COATING COMPOSITIONS - coating composition comprising a starchy material said material having: a number average molecular weight of 3 500 to 20 000 08-28-2008
512. 20080206146 Functionalized Magnetic Nanoparticles and Methods of Use Thereof 08-28-2008
513. 20080206127 Iron Oxide Precipitaion from Acidic Iron Salt Solutions 08-28-2008
514. 20080202933 Microfluidic Detection of Analytes - apparatus and methods for concentrating samples for application to microfluidic devices are disclosed 08-28-2008
515. 20080200491 1,2-Dihydro-Spiro[3H-Indole-3,4'-Piperidine] Compounds, as Modulators of the Mas Receptor Novel 08-21-2008
516. 20080200416 Modulation of T cell signaling threshold and T cell sensitivity to antigens 08-21-2008
517. 20080199888 Non-endogenous, constitutively activated versions of human G protein coupled receptor: FSHR 08-21-2008
518. 20080199887 COMPOUNDS AND METHODS FOR USE IN DETECTING GABAPENTIN 08-21-2008
519. 20080199539 HEMOSTATIC COMPOSITIONS AND METHODS OF USE 08-21-2008
520. 20080199474 Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia 08-21-2008
521. 20080199463 METHOD FOR TREATING MULTIPLE MYELOMA - methods for the treatment of multiple myeloma 08-21-2008
522. 20080199462 PREVENTING AIRWAY MUCUS PRODUCTION BY ADMINISTRATION OF EGF-R ANTAGONISTS 08-21-2008
523. 20080199432 ROLE FOR SRY IN PARKINSON'S DISEASE - method for treating or preventing Parkinson's disease in a patient 08-21-2008
524. 20080197026 TRANSITION METAL COMPLEXES WITH (PYRIDYL)IMIDAZOLE LIGANDS 08-21-2008